Molecular insights and therapeutic targets for diabetic endothelial dysfunction
- PMID: 19786641
- PMCID: PMC2910587
- DOI: 10.1161/CIRCULATIONAHA.108.835223
Molecular insights and therapeutic targets for diabetic endothelial dysfunction
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2910587/bin/nihms215845f1.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2910587/bin/nihms215845f2.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2910587/bin/nihms215845f3.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2910587/bin/nihms215845f4.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2910587/bin/nihms215845f5.gif)
![Figure 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2910587/bin/nihms215845f6.gif)
![Figure 7](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2910587/bin/nihms215845f7.gif)
![Figure 8](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2910587/bin/nihms215845f8.gif)
Similar articles
-
Type II Diabetes Mellitus and Endothelial Dysfunction: What Can We Do?Isr Med Assoc J. 2021 Feb;23(2):121-122. Isr Med Assoc J. 2021. PMID: 33595219 No abstract available.
-
Diabetic Endothelium Dysfunction, Cardiovascular Complications, and Therapeutics.J Diabetes Res. 2016;2016:5349801. doi: 10.1155/2016/5349801. Epub 2016 Feb 18. J Diabetes Res. 2016. PMID: 26989698 Free PMC article. No abstract available.
-
Endothelial function and the prediction of CVD in diabetes.Curr Diab Rep. 2006 Feb;6(1):17-21. doi: 10.1007/s11892-006-0046-3. Curr Diab Rep. 2006. PMID: 16522276 Review.
-
Microalbuminuria, endothelial dysfunction and cardiovascular risk.Diabetes Metab. 2000 Jul;26 Suppl 4:64-6. Diabetes Metab. 2000. PMID: 10922975 Review.
-
[Therapeutic strategies in the treatment of endothelial dysfunction: facts and outlook].Ital Heart J Suppl. 2000 Feb;1(2):212-21. Ital Heart J Suppl. 2000. PMID: 10731378 Review. Italian.
Cited by
-
Endothelial dysfunction in vascular complications of diabetes: a comprehensive review of mechanisms and implications.Front Endocrinol (Lausanne). 2024 Apr 5;15:1359255. doi: 10.3389/fendo.2024.1359255. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38645427 Free PMC article. Review.
-
Predictors of non-obstructive coronary slow flow in poorly controlled type 2 diabetes mellitus: a cross-sectional study.BMC Cardiovasc Disord. 2024 Feb 1;24(1):83. doi: 10.1186/s12872-024-03738-w. BMC Cardiovasc Disord. 2024. PMID: 38302950 Free PMC article.
-
SGLT2 inhibitor improves the prognosis of patients with coronary heart disease and prevents in-stent restenosis.Front Cardiovasc Med. 2024 Jan 11;10:1280547. doi: 10.3389/fcvm.2023.1280547. eCollection 2023. Front Cardiovasc Med. 2024. PMID: 38274313 Free PMC article. Review.
-
Advances in Fabrication Technologies for the Development of Next-Generation Cardiovascular Stents.J Funct Biomater. 2023 Nov 10;14(11):544. doi: 10.3390/jfb14110544. J Funct Biomater. 2023. PMID: 37998113 Free PMC article. Review.
-
Association between glycated hemoglobin and functional outcomes in patients with intracranial large artery atherosclerotic disease-related acute ischemic stroke: identifying the magic number.Front Neurol. 2023 Sep 27;14:1249535. doi: 10.3389/fneur.2023.1249535. eCollection 2023. Front Neurol. 2023. PMID: 37830089 Free PMC article.
References
-
- Zou MH, Cohen R, Ullrich V. Peroxynitrite and vascular endothelial dysfunction in diabetes mellitus. Endothelium. 2004;11:89–97. - PubMed
-
- Brunner H, Cockcroft JR, Deanfield J, Donald A, Ferrannini E, Halcox J, Kiowski W, Luscher TF, Mancia G, Natali A, Oliver JJ, Pessina AC, Rizzoni D, Rossi GP, Salvetti A, Spieker LE, Taddei S, Webb DJ. Endothelial function and dysfunction, part II: association with cardiovascular risk factors and diseases: a statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension. J Hypertens. 2005;23:233–246. - PubMed
-
- Caballero AE. Endothelial dysfunction, inflammation, and insulin resistance: a focus on subjects at risk for type 2 diabetes. Curr Diab Rep. 2004;4:237–246. - PubMed
-
- Vane JR, Anggard EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med. 1990;323:27–36. - PubMed
-
- Deanfield J, Donald A, Ferri C, Giannattasio C, Halcox J, Halligan S, Lerman A, Mancia G, Oliver JJ, Pessina AC, Rizzoni D, Rossi GP, Salvetti A, Schiffrin EL, Taddei S, Webb DJ. Endothelial function and dysfunction, part I: methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension. J Hypertens. 2005;23:7–17. - PubMed
Publication types
MeSH terms
Grants and funding
- HL074399/HL/NHLBI NIH HHS/United States
- R01 HL089920/HL/NHLBI NIH HHS/United States
- HL080499/HL/NHLBI NIH HHS/United States
- R01 HL079584-07/HL/NHLBI NIH HHS/United States
- R01 HL079584/HL/NHLBI NIH HHS/United States
- R01 HL079584-08/HL/NHLBI NIH HHS/United States
- R01 HL074399-06/HL/NHLBI NIH HHS/United States
- R01 HL080499/HL/NHLBI NIH HHS/United States
- R01 HL096032-01/HL/NHLBI NIH HHS/United States
- R01 HL089920-03/HL/NHLBI NIH HHS/United States
- HL096032/HL/NHLBI NIH HHS/United States
- R01 HL080499-04/HL/NHLBI NIH HHS/United States
- R01 HL080499-03/HL/NHLBI NIH HHS/United States
- R01 HL074399/HL/NHLBI NIH HHS/United States
- HL089920/HL/NHLBI NIH HHS/United States
- HL079584/HL/NHLBI NIH HHS/United States
- R01 HL096032-02/HL/NHLBI NIH HHS/United States
- R01 HL110488/HL/NHLBI NIH HHS/United States
- R01 HL080499-05/HL/NHLBI NIH HHS/United States
- R01 HL105157/HL/NHLBI NIH HHS/United States
- R01 HL074399-07/HL/NHLBI NIH HHS/United States
- R01 HL089920-02/HL/NHLBI NIH HHS/United States
- R01 HL096032/HL/NHLBI NIH HHS/United States
- R01 HL089920-04/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources